Amayak Grachevich Broutian

Amayak Grachevich Broutian

Auto-generated profile, based on publicly available information

Amayak Grachevich Broutian

Research Center of Neurology

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2023 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
TPT. N. Pushkar
T. N. Pushkar
PVP. N. Vlasov
P. N. Vlasov
ABAlexandra Belyakova-Bodina
Alexandra Belyakova-Bodina
ABA. G. Broutian
A. G. Broutian
Cefepime is a fourth-generation cephalosporin antibiotic widely used in clinical practice for various organ systems pathology treatment. The article describes the clinical observation of a patient who, 3 days after cefepime administration, had a decrease in the level of consciousness, regarded as encephalopathy. Cefepime-induced neurotoxicity is characterized by toxic encephalopathy, which manifests 2–6 days after the start of the treatment with this drug and disappears 1–3 days after its withdrawal. Electroencephalography (EEG) abnormalities include generalized periodic discharges (GPR) of triphasic morphology or a pattern corresponding to the criteria for non-convulsive status epilepticus (BSES). In our observation, the EEG recorded stimulus-induced GPRs of triphasic morphology with a frequency of 1.5 Hz; a test with intravenous administration of an antiepileptic drug (levetiracetam) was negative. A day after the withdrawal of cefepime, the patient’s level of consciousness returned to the initial level, and on the EEG periodic discharges completely regressed. Thus, cefepime may cause encephalopathy in patients with rhythmic or intermittent EEG activity, especially in the presence of a stimulus-induced component. In some cases, the use of cefepime may develop epileptic seizures and BSES.


1 January 2020 in Clinical Neurophysiology Practice
Verified
Journal Article
Open access
ABAmayak Broutian
Amayak Broutian
SDSnezhana Dolgova
Snezhana Dolgova
ABAlexandra Belyakova-Bodina
Alexandra Belyakova-Bodina
AAAnna Abramova
Anna Abramova
ALAnastasia Lukianova
Anastasia Lukianova
TNTatiana Noskova
Tatiana Noskova
We present a case of idiopathic generalized epilepsy (IGE) with seizures manifesting in the context of Graves disease and unusual interictal EEG pattern of bilateral independent 3 Hz spike and wave activity. A 33-year old man with three generalized tonic-clonic seizures (GTCS) in history admitted for overnight video-EEG. At the age of 28, he had his first seizure soon after being diagnosed with Graves' disease. For four years, he received thiamazole and then underwent total thyroidectomy. EEG showed a high number of generalized 3-Hz spike-and-wave discharges (GSWD) but also revealed numerous runs of bitemporal independent lateralized 3-Hz spike-and-wave activity (LSWA). GSWD and LSWA were mostly independent and had slightly different morphology. A diagnosis of IGE with GTCS upon awakening was made. On levetiracetam therapy, the patient demonstrated no seizure recurrence during 2-year follow-up. Repeated overnight EEG showed significant GSWD reduction and complete LSWA suppression. To our knowledge, in patients with IGE, strictly lateralized spike-and-wave activity was never reported. In this case, thyroid dysfunction seemed to increase propensity to generate spontaneous seizures. We speculate that thyroid dysfunction superimposed on IGE thalamocortical network oscillations resulted in uncommon bitemporal independent LSWA.

19 December 2023 in Clinical Neurophysiology Practice
Verified
Journal Article
Open access
ABAmayak Broutian
Amayak Broutian
YSYulia Shpilyukova
Yulia Shpilyukova
ABAlexandra Belyakova-Bodina
Alexandra Belyakova-Bodina
AAAnna Abramova
Anna Abramova
OKOlga Korepina
Olga Korepina
RKRodion Konovalov
Rodion Konovalov
Creutzfeldt-Jakob disease (CJD) is a devastating degenerative brain disorder caused by an abnormal isoform of a cellular glycoprotein which is known as the prion protein. A diagnosis of CJD is usually based on specific clinical signs, EEG and MRI findings, as well as the presence of the 14–3-3 protein in the cerebrospinal fluid. Although end-stage CJD usually has a typical clinical presentation, early symptoms may be variable. We present an uncommon case of CJD which manifested with primary progressive aphasia, leading to an incorrect diagnosis of frontotemporal dementia. EEG performed eight months after symptom onset revealed focal periodic sharp wave complexes that later evolved into diffuse EEG abnormalities characteristic of CJD. Brain MRI also suggested the diagnosis of CJD. Later, the patient developed rapidly progressive dementia, visual symptoms, ataxia, extrapyramidal symptoms, followed by dysphagia and mutism, and died 34 months after disease onset. PPA is a relatively uncommon first manifestation of CJD, occurring only in about 1% of all CJD cases. Our case is also remarkable because we were able to capture focal periodic sharp wave complexes at the stage of the CJD when aphasia was the only clinical manifestation. We demonstrate that both brain MRI and wake and sleep EEG should be a mandatory part of the diagnostic workup for patients presenting with primary progressive aphasia.

23 October 2021 in Physical and rehabilitation medicine, medical rehabilitation
Verified
Journal Article
Open access
PDF file
ACAnastasiia N. Cherkasova
Anastasiia N. Cherkasova
KYKseniia A. Yatsko
Kseniia A. Yatsko
MKMaria S. Kovyazina
Maria S. Kovyazina
NVNataliya Varako
Nataliya Varako
MKMarina V. Krotenkova
Marina V. Krotenkova
РВРябинкина Юлия Валерьевна
Рябинкина Юлия Валерьевна
The detection of signs of consciousness in patients with chronic disorders of consciousness is a complex clinical task. In recent decades, instrumental methods have been used to improve the accuracy of diagnostics. The phenomenon of covert cognition and cognitive motor dissociation have been demonstrated in a small proportion of patients in studies using instrumental methods in combination with different paradigms. This article describes the main features of the diagnostic paradigms used for such purposes. Currently, the development of its own complex of paradigms is held at the Research Center of Neurology collaboratively with group of neuropsychologists from Lomonosov Moscow State University. The general characteristics of this complex of paradigms are indicated. The practical significance of detecting the phenomenon of covert cognition and cognitive motor dissociation in patients with chronic disorders of consciousness is discussed.

2 May 2025 in Epilepsy and paroxysmal conditions
Verified
Journal Article
Closed access
MMMarina Maksimova
Marina Maksimova
EGE. A. Golovneva
E. A. Golovneva
ABA. G. Broutian
A. G. Broutian
ECE. O. Chekanova
E. O. Chekanova
MZMariya N. Zakharova
Mariya N. Zakharova
Background. Epileptic seizures are involved in the diagnostic criteria for autoimmune encephalitis (AE). In this regard, timing of onset of focal-to-bilateral tonic-clonic seizure (BTCS) transition and status epilepticus (SE) in AE is understudied.Objective: to compare the timing of onset for focal-to-BTCS and SE during AE.Material and methods. Examination of patients with AE included collecting patient history, conducting blood and cerebrospinal fluid tests, magnetic resonance imaging, and long-term electroencephalographic video-monitoring. Out of 41 examined patients, 22 (54%) were diagnosed with “suspected AE” and 19 (46%) patients had “verified AE”. Focal-to-BTCS were noted in patient history of 36 (88%) subjects, including subsequent SE observed in 12 (29%) cases.Results. A single focal-to-BTCS/SE was the first AE symptom found in 8 (22%) patients, including 1 patient bearing antibodies against glutamate decarboxylase 65 (GAD65). In 8 (22%) cases, AE manifested with focal seizures, whereas focal-to-BTCS and/or SE developed later. This type of AE course was most commonly observed in patients with anti-GAD65 antibody-positive encephalitis (4 out of 9 cases). Focal-to-BTCS and SE developed only at disease onset and during exacerbations of the immune process in 5 (14%) patients, 2 of whom carried anti-myelin oligodendrocyte glycoprotein antibodies.Conclusion. Focal-to-BTCS and SE most often emerge at AE onset. Anti-GAD65 antibody-positive encephalitis is manifested by long-lasting drug-resistant epilepsy with late onset of focal-to-BTCS and SE. In case of anti-GAD65 antibody-positive AE, epileptic seizures occur only at disease onset.